SIA
HAE icon

Sit Investment Associates’s Haemonetics HAE Stock Holding History

Sit Investment Associates’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-72,654
Closed -$3.06M – 461
2013
Q4 		$3.06M Sell
72,654
-2,300
-3% -$94.6K 0.05% 242
2013
Q3 		$2.99M Hold
74,954
– – 0.06% 233
2013
Q2 		$3.1M Buy
+74,954
New +$3.03M 0.06% 224

Other funds holding HAE

Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Sit Investment Associates's HAE Position: Q1 2014 in Review

Sit Investment Associates sold out of Haemonetics (HAE) in Q1 2014, closing a stake of 72,654 shares — an estimated $3.06M sold.

Sit Investment Associates first reported a position in HAE in Q2 2013 and held it in 3 quarters. The position peaked at $3.1M in Q2 2013. 192 funds tracked by Wall St. Rank hold HAE as of Q1 2014.

  • Sit Investment Associates reported no remaining Haemonetics position as of Q1 2014 after selling out during the quarter.
  • Sit Investment Associates sold 72,654 Haemonetics shares in Q1 2014, an estimated $3.06M.
  • Sit Investment Associates first reported a position in Haemonetics in Q2 2013 and held it in 3 quarters.
  • Sit Investment Associates's Haemonetics position peaked at $3.1M in Q2 2013.
  • 192 funds tracked by Wall St. Rank held Haemonetics as of Q1 2014.

Based on Sit Investment Associates's 13F filing for Q1 2014, filed 24 Apr 2014.